MS
People With MS Disproportionately at Risk for Hospitalization and Death From COVID-19
Even after receiving at least three COVID-19 vaccinations, people with MS had an almost six times greater risk for ...
APRIL 30, 2024
FDA Approves New Oral Mavenclad for MS
Following the administration of two treatment courses, additional courses of cladribine are not to be administered ...
APRIL 1, 2019
FDA Approves Oral Drug for Relapsing Forms of MS
Mayzent is the first and only treatment specifically approved for patients with active secondary progressive ...
MARCH 27, 2019
Vitamin D3 May Benefit MS Patients
High doses of vitamin D3 may help regulate the hyperactive immune response in MS.
JANUARY 8, 2016
Load more